0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli]

6 MG/ML · Injection · injection

A form of ranibizumab-eqrn →

0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli] — Antineovascularisation agents. Strength, form, class, interactions & more.

0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli]

Active ingredient

Classification

Antineovascularisation agentsVascular Endothelial Growth Factor Inhibitor

Drug interactions

No specific drug interactions have been identified for ranibizumab-eqrn, but caution is advised when used with photodynamic therapy (PDT).

  • unknownphotodynamic therapy (PDT) — serious intraocular inflammation may occur

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.